Publications by authors named "Komal Bawa"

Claim this Profile
C
Clinical practice guidelines for the treatment and management of diabetic macular oedema: a systematic review.
Mark McAllister, Stella Ko, Komal Bawa, Elizabeth Mearns, David Tabano

Eye (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of clinical practice guidelines for the management of neovascular age-related macular degeneration.
Jennifer I Lim, Stella Ko, Mark McAllister, Nancy Faux, Komal Bawa

Eye (Lond)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis.
Gabriel Pardo, Elmor D Pineda, Carmen D Ng, Komal K Bawa, Daniel Sheinson

Neurol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' access to rare neuromuscular disease therapies varies across US private insurers.
Nikoletta M Margaretos, Komal Bawa, Natalie J Engmann, James D Chambers

Orphanet J Rare Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data.
Natalie J Engmann, Danny Sheinson, Komal Bawa, Carmen D Ng, Gabriel Pardo

J Manag Care Spec Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an institution-wide guideline for hyperglycemic emergencies at a tertiary academic medical center.
Nahal Beik, Kevin E Anger, Allison A Forni, Komal Bawa, Paul M Szumita

Ann Pharmacother· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis